(Q34792137)

4 August 2017

title

Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5). (English)

1 reference

4 August 2017

1 reference

Tunde Peto

4

0 references

Michel Michaelides

5

object named as

Michel Michaelides

1 reference

4 August 2017

Sobha Sivaprasad

1

1 reference

4 August 2017

Roxanne Crosby-Nwaobi

2

1 reference

4 August 2017

Ling Zhi Heng

3

1 reference

4 August 2017

Phil Hykin

6

1 reference

4 August 2017

language of work or name

English

0 references

publication date

3 July 2013

1 reference

British Journal of Ophthalmology

4 August 2017

published in

1 reference

4 August 2017

volume

97

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1177-1180

1 reference

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Association between photoreceptor integrity and visual outcome in diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

Association of pathomorphology, photoreceptor status, and retinal thickness with visual acuity in diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2013-303168

10.1136/BJOPHTHALMOL-2013-303168

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference